OxyContin Maker Explored Expansion Into Anti-Addiction Market

Secret portions of a lawsuit allege that Purdue Pharma considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.

Source link

Related posts

What are the 10 most eminently curable neurological disorders?


Long-term Lamotrigine, Levetiracetam Comparable to Brand Name Drugs in Epilepsy


Author response: Personalizing acute therapies for ischemic stroke: Thrombolysis or thrombectomy?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy